Neurochemical Research
-
Publication Venue For
- Roles of glutamine synthetase inhibition in epilepsy.. 37:2339-2350. 2012
- Increased expression of p130 in Alzheimer disease.. 32:639-644. 2007
- Elevation in plasma Abeta42 in geriatric depression: a pilot study.. 31:341-349. 2006
- Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure.. 31:367-381. 2006
- Baseline plasma GABA: its relationship to the adverse effects of acute lorazepam administration on cognition in the elderly.. 29:2311-2315. 2004
- The recurrent mossy fiber pathway of the epileptic brain.. 28:1649-1658. 2003
- Phosphorylation state, solubility, and activity of calcium/calmodulin-dependent protein kinase II alpha in transient focal ischemia in mouse brain.. 27:477-484. 2002
- Sarin causes early differential alteration and persistent overexpression in mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of rats.. 27:407-415. 2002
- Early differential elevation and persistence of phosphorylated cAMP-response element binding protein (p-CREB) in the central nervous system of hens treated with diisopropyl phosphorofluoridate, an OPIDN-causing compound.. 27:183-193. 2002
- Sarin causes altered time course of mRNA expression of alpha tubulin in the central nervous system of rats.. 27:177-181. 2002
- Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride.. 26:235-243. 2001
- Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).. 26:43-50. 2001
- Early differential induction of C-jun in the central nervous system of hens treated with diisopropylphosphorofluoridate (DFP).. 25:1579-1586. 2000
- Alterations in levels of mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).. 25:809-816. 2000
- C-fos mRNA induction in the central and peripheral nervous systems of diisopropyl phosphorofluoridate (DFP)-treated hens.. 25:327-334. 2000
- Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.. 24:1203-1207. 1999
- Effect of halothane in cortical cell cultures exposed to N-methyl-D-aspartate.. 23:17-23. 1998
- Neurofilament phosphorylation and [125I]calmodulin binding by Ca2+/calmodulin-dependent protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hen.. 20:1095-1105. 1995
- In vitro binding of [14C]2,5-hexanedione to rat neuronal cytoskeletal proteins.. 19:1165-1173. 1994
- In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization.. 19:435-444. 1994
- Comparison of Ca2+/calmodulin-dependent protein kinase II purified from control and diisopropyl phosphorofluoridate (DFP)-treated hens.. 18:259-269. 1993
- Tetrahydropapaveroline and salsolinol alter 45Ca2+ efflux within perfused hippocampus of unrestrained rats.. 13:989-995. 1988
- Examination of a nerve injury-induced, 37 kDa protein: purification and characterization.. 12:967-976. 1987
- Rate of in vivo verapamil exchange within the hypothalamus of the cat as examined by push-pull perfusion.. 11:1643-1651. 1986
- L-glutamine D-fructose-6-P aminotransferase regulation by glucose-6-P and UDP-N-acetylglucosamine.. 8:1589-1595. 1983
- Age related changes in blood-to-brain amino acid transport and incorporation into brain protein.. 8:167-177. 1983
- Tissue and regional distribution of cysteic acid decarboxylase. A new assay method.. 4:201-212. 1979
- Distribution and tissue specificity of 4-aminobutyrate-2-oxoglutarate aminotransferase.. 3:207-219. 1978